The possibility of new PrEP drug raises questions about how to fix gaps in data on women. Medicare will cover CAR-T cell therapy with significant moves to broaden administration and eligible patients. Sarepta denies a serious patient response to its Duchenne’s therapy, but its stock plunges.
Event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men
The roll-out of pre-exposure prophylaxis (PrEP) provides an opportunity to bring down the incidence of sexually transmitted infections (STIs), provided that PrEP and STI programmes are better co-ordinated and integrated
It took universal health care, political will and a health campaign designed to terrify the public, but nearly four decades into the H.I.V. crisis, Australian researchers say the country is on a path toward making transmissions of the virus vanishingly rare.
Australia has solidified its reputation as a world leader in HIV prevention, recording its lowest number of new HIV cases in almost two decades.
Sometimes it is best to go where everyone does not know your name, but where you feel welcome just the same.
Ending HIV – a community-focused behavior change program run by the New Zealand AIDS Foundation ‘Rules of a f***buddy’ has launched a campaign created by DDB NZ and to reach men who have sex with men.
Gay men are already a socially marginalised and stigmatised group – their health can no longer continue to be sacrificed, National Aids Trust's Yused Azad writes
Adolescents who take pre-exposure prophylaxis, or PrEP, for HIV prevention may experience a loss of bone mineral density during treatment.
With its latest recommendation, published in JAMA, the U.S. Preventive Services Task Force (USPSTF) issued its strongest strategy yet for preventing HIV.
The consistent and steady decline in HIV is related to the power of an increasingly better known, life-saving HIV treatment that has the wonderful side effect of preventing sexual transmission.
Congress questioned Gilead's CEO about the high price of HIV prevention drug Truvada. Rep. Alexandria Ocasio-Cortez didn't hold back.